NanoViricides
NNVC
#10523
Rank
ยฃ27.18 M
Marketcap
ยฃ1.06
Share price
6.77%
Change (1 day)
-16.74%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of June 2026 : ยฃ7.39 Million

According to NanoViricides's latest financial reports the company's total assets are ยฃ7.39 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2024)

Total assets by year

Year Total assets Change
2023-06-30ยฃ13.29 M-31.19%
2022-06-30ยฃ19.32 M-11.71%
2021-06-30ยฃ21.88 M13.37%
2020-06-30ยฃ19.3 M82.2%
2019-06-30ยฃ10.59 M-24.55%
2018-06-30ยฃ14.04 M-32.37%
2017-06-30ยฃ20.75 M-24.47%
2016-06-30ยฃ27.48 M-2.43%
2015-06-30ยฃ28.16 M9.88%
2014-06-30ยฃ25.63 M137.55%
2013-06-30ยฃ10.79 M8.32%
2012-06-30ยฃ9.96 M48.61%
2011-06-30ยฃ6.7 M13.06%
2010-06-30ยฃ5.92 M225.54%
2009-06-30ยฃ1.82 M146.91%
2008-06-30ยฃ0.73 M9.37%
2007-06-30ยฃ0.67 M-54.83%
2006-06-30ยฃ1.49 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
ยฃ36.99 B 499,838.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ97.28 B 1,314,535.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ66.53 B 898,983.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ71.27 B 963,115.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
ยฃ0.71 B 9,578.07%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.41 B 5,549.92%๐Ÿ‡บ๐Ÿ‡ธ USA